01 May 2019 --- Biotechnology company Gelesis’ weight management prescription drug, Plenity, has been cleared by the US Food and Drug Administration (FDA) for use in obese adults, when taken in conjunction with an appropriate diet and exercise. The company is now seeking EU marketing clearance and is in discussions with global and regional strategic partners to enable a successful international launch, a company spokesperson tells NutritionInsight.
